Biotricity Inc. (BTCY) 2.5400 $BTCY
New Wearable Devices in the Medical and Diagnostic Sectors
PR Newswire - Tue Aug 30, 8:00AM CDT
A new segment of the wearable devices market is emerging and it is with a focus on medical and diagnostic purposes. The diagnostic wearable medical devices are using technology to remotely monitor, control, and track individual's vital signs. According to a recent report by Researchmoz, the global diagnostic wearable medical devices market is set to grow at a CAGR of 14.01% during the period 2016-2020. Biotricity Inc. (OTCQB: BTCY), DexCom, Inc. (NASDAQ: DXCM), Siemens AG (OTC: SIEGY), Alphabet Inc. (NASDAQ: GOOGL), Fitbit Inc. (NASDAQ: FIT).
FIT: 16.27 (+0.33), DXCM: 93.50 (+0.75), GOOGL: 805.03 (+5.25)
biotricity to Present at the 5th Annual Liolios Gateway Conference on September 8, 2016
GlobeNewswire - Mon Aug 22, 8:00AM CDT
biotricity, Inc. (OTCQB:BTCY), a healthcare technology company dedicated to delivering innovative, medically relevant biometric remote monitoring solutions, has been invited to present at the 2016 Gateway Conference being held on September 7-8, 2016 at the Four Seasons Hotel in San Francisco.
Wearable Medical Devices and the Internet of Things
PR Newswire - Tue Aug 16, 8:05AM CDT
The Internet of Things (IoT) is the biggest technological revolution since the democratization of the internet itself. That is because of the wide range of applications for which IoT can be used. As of right now, the IoT mostly impresses us in combination with wearable technology, specifically fitness trackers and smart watches. But a new wave of wearable devices is becoming an important component of tech companies; medical wearable devices. Biotricity Inc. (OTC: BTCY), Fitbit Inc. (NASDAQ: FIT), Garmin Ltd. (NASDAQ: GRMN), Siemens AG (OTC: SIEGY), Alphabet Inc. (NASDAQ: GOOGL)
FIT: 16.27 (+0.33), GRMN: 48.36 (+0.81), GOOGL: 805.03 (+5.25)
Biotricity Selects AT&T to Provide Network Connectivity for its Remote Monitoring Solutions
GlobeNewswire - Tue Aug 02, 7:00AM CDT
Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, has selected AT&T, Inc. as its preferred network partner for providing connectivity to the company's medical devices.
Wearable Devices Market Continues to Show Strength
PR Newswire Europe - Mon Aug 01, 8:01AM CDT
NEW YORK, August 1, 2016 /PRNewswire/ --
FIT: 16.27 (+0.33), GPRO: 14.97 (+0.71), MDT: 87.14 (+0.78), GRMN: 48.36 (+0.81)
Biotricity CEO Pedigree on Par with Worldwide Tech Giants
ACCESSWIRE - Mon Jun 20, 7:30AM CDT
NEW YORK, NY / ACCESSWIRE / June 20, 2016 / Conventional wisdom of the past several decades presumes higher education equates with business success. It's what our children strive for; however, this is not always true. Example: multi-billionaire Mark Zuckerberg dropped out of Harvard University to devote himself to a computer program that became global social phenomenon Facebook.
Biotricity Files for FDA 510(k)
GlobeNewswire - Mon Jun 20, 7:30AM CDT
Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, has filed for a 510(k) with the U.S. Food and Drug Administration (FDA). Biotricity expects to receive a response from the FDA on its 510(k) submission by early Fall.
Wearable Devices in the Medical Sector
PR Newswire - Tue Jun 07, 10:45AM CDT
http://www.FinancialBuzz.com: Wearable devices is an enormous market with constant advancement in technologies. A market research by IDTechEx Research shows how the wearable devices market was segmented in 2015. The largest segment, Advanced Infotainment, which mostly includes all the smart watches from Apple, and Samsung that sync with smartphones and tablets. The second largest segment is the one with long term prospects and technological potential, the Health, Medical, Fitness and Wellness segment. Biotricity Inc. (OTC: BTCY), Koninklijke Philips NV (NYSE: PHG), Medtronic PLC (NYSE: MDT), Fitbit Inc. (NYSE: FIT), Apple Inc. (NASDAQ: AAPL)
FIT: 16.27 (+0.33), PHG: 29.16 (+0.36), MDT: 87.14 (+0.78), AAPL: 113.55 (-0.02)
Biotricity Adds Two Members to Its Board of Advisors
GlobeNewswire - Mon Jun 06, 8:00AM CDT
Biotricity, Inc. (OTCQB:BTCY), a healthcare technology company dedicated to delivering innovative, medically relevant biometric remote monitoring solutions, has appointed Thomas Nelson and J. Bernard Rice to its newly formed Board of Advisors (BOA).
Biotricity to Present at LD Micro Invitational Investor Conference on June 7, 2016
ACCESSWIRE - Tue May 24, 8:01AM CDT
REDWOOD CITY, CA / ACCESSWIRE / May 24, 2016 / Biotricity, Inc. (OTCQB: BTCY), a healthcare technology company dedicated to delivering innovative, medically relevant biometric remote monitoring solutions, has been invited to present at the sixth annual LD Micro Invitational, being held June 7-9, 2016 at the Luxe Sunset Bel Air.
Biotricity Establishes Board of Advisors
GlobeNewswire - Tue May 10, 7:00AM CDT
Biotricity, Inc. (OTCQB:BTCY), a healthcare technology company dedicated to delivering innovative, medically relevant biometric remote monitoring solutions, has established its board of advisors comprised of policy leader and former AARP executive John Rother and healthcare informatics professional Dr. Danny Sands. This team of experts will provide non-binding strategic advice to Biotricity as it continues to develop its next generation wearable devices.
Biotricity Appoints Norman Betts to Board of Directors
GlobeNewswire - Wed Apr 27, 8:00AM CDT
Biotricity, Inc. (OTCQB:BTCY), a healthcare technology company dedicated to delivering innovative, medically relevant biometric remote monitoring solutions, has appointed financial professional Norman Betts to the company's board of directors. An accomplished accountant and professor, Betts also currently serves as a board member for the Bank of Canada, the country's central bank and the Canadian equivalent to the Federal Reserve. He is the second board member, and first independent, to join Biotricity with others expected to be added during the second quarter.
Over 70% of Americans Would Buy A Health Tracking Device if Clinically Accurate
ACCESSWIRE - Wed Apr 20, 7:00AM CDT
REDONDO BEACH, CA / ACCESSWIRE / April 20, 2016 / More than eight in ten consumers believe that tracking their own health data with a clinically accurate monitoring device will help improve their overall health, while over 70% of adults would use a personal monitoring device if it were clinically accurate, according to a survey commissioned by Biotricity Inc. (OTCQB: BTCY) and the Society for Participatory Medicine.
FIT: 16.27 (+0.33), CSII: 24.00 (+0.15), MDT: 87.14 (+0.78), BEAT: 18.65 (+0.43), CRY: 18.28 (+0.42), AAPL: 113.55 (-0.02)
Biometric Monitoring Solutions Provider, Biotricity, Begins Trading on the OTC QB Market as "BTCY"
GlobeNewswire - Wed Feb 03, 11:55AM CST
iMedical Innovation Inc., dba Biotricity, a healthcare technology company dedicated to delivering innovative, medically relevant biometric monitoring solutions, has completed a "reverse merger" transaction with Metasolutions Inc. (OTCQB:BTCY), a U.S.-based publicly-traded provider of, until the closing, energy intelligence management solutions, at which time all of its assets and liabilities were assigned to and assumed by a third party.
New Research From Biotricity and the Society for Participatory Medicine Finds Consumers Ready to Take Active Role in Managing Health & Illness
GlobeNewswire - Tue Feb 02, 9:00AM CST
Americans are fully prepared to take a more active role in managing their over-all health and are more than willing to wear personal monitoring devices to help themselves and medical professionals improve their care. According to a national survey of 1,000 respondents commissioned by The Society for Participatory Medicine and healthcare technology company Biotricity Inc., and more than 8 out of 10 consumers (84 percent) believe that tracking their own health data with a clinically accurate monitoring device will help improve their over-all health.
New Wearable Devices in the Medical and Diagnostic Sectors
PR Newswire - Tue Aug 30, 8:00AM CDT
A new segment of the wearable devices market is emerging and it is with a focus on medical and diagnostic purposes. The diagnostic wearable medical devices are using technology to remotely monitor, control, and track individual's vital signs. According to a recent report by Researchmoz, the global diagnostic wearable medical devices market is set to grow at a CAGR of 14.01% during the period 2016-2020. Biotricity Inc. (OTCQB: BTCY), DexCom, Inc. (NASDAQ: DXCM), Siemens AG (OTC: SIEGY), Alphabet Inc. (NASDAQ: GOOGL), Fitbit Inc. (NASDAQ: FIT).
FIT: 16.27 (+0.33), DXCM: 93.50 (+0.75), GOOGL: 805.03 (+5.25)
biotricity to Present at the 5th Annual Liolios Gateway Conference on September 8, 2016
GlobeNewswire - Mon Aug 22, 8:00AM CDT
biotricity, Inc. (OTCQB:BTCY), a healthcare technology company dedicated to delivering innovative, medically relevant biometric remote monitoring solutions, has been invited to present at the 2016 Gateway Conference being held on September 7-8, 2016 at the Four Seasons Hotel in San Francisco.
Wearable Medical Devices and the Internet of Things
PR Newswire - Tue Aug 16, 8:05AM CDT
The Internet of Things (IoT) is the biggest technological revolution since the democratization of the internet itself. That is because of the wide range of applications for which IoT can be used. As of right now, the IoT mostly impresses us in combination with wearable technology, specifically fitness trackers and smart watches. But a new wave of wearable devices is becoming an important component of tech companies; medical wearable devices. Biotricity Inc. (OTC: BTCY), Fitbit Inc. (NASDAQ: FIT), Garmin Ltd. (NASDAQ: GRMN), Siemens AG (OTC: SIEGY), Alphabet Inc. (NASDAQ: GOOGL)
FIT: 16.27 (+0.33), GRMN: 48.36 (+0.81), GOOGL: 805.03 (+5.25)
Biotricity Selects AT&T to Provide Network Connectivity for its Remote Monitoring Solutions
GlobeNewswire - Tue Aug 02, 7:00AM CDT
Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, has selected AT&T, Inc. as its preferred network partner for providing connectivity to the company's medical devices.
Wearable Devices Market Continues to Show Strength
PR Newswire Europe - Mon Aug 01, 8:01AM CDT
NEW YORK, August 1, 2016 /PRNewswire/ --
FIT: 16.27 (+0.33), GPRO: 14.97 (+0.71), MDT: 87.14 (+0.78), GRMN: 48.36 (+0.81)
Biotricity CEO Pedigree on Par with Worldwide Tech Giants
ACCESSWIRE - Mon Jun 20, 7:30AM CDT
NEW YORK, NY / ACCESSWIRE / June 20, 2016 / Conventional wisdom of the past several decades presumes higher education equates with business success. It's what our children strive for; however, this is not always true. Example: multi-billionaire Mark Zuckerberg dropped out of Harvard University to devote himself to a computer program that became global social phenomenon Facebook.
Biotricity Files for FDA 510(k)
GlobeNewswire - Mon Jun 20, 7:30AM CDT
Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, has filed for a 510(k) with the U.S. Food and Drug Administration (FDA). Biotricity expects to receive a response from the FDA on its 510(k) submission by early Fall.
Wearable Devices in the Medical Sector
PR Newswire - Tue Jun 07, 10:45AM CDT
http://www.FinancialBuzz.com: Wearable devices is an enormous market with constant advancement in technologies. A market research by IDTechEx Research shows how the wearable devices market was segmented in 2015. The largest segment, Advanced Infotainment, which mostly includes all the smart watches from Apple, and Samsung that sync with smartphones and tablets. The second largest segment is the one with long term prospects and technological potential, the Health, Medical, Fitness and Wellness segment. Biotricity Inc. (OTC: BTCY), Koninklijke Philips NV (NYSE: PHG), Medtronic PLC (NYSE: MDT), Fitbit Inc. (NYSE: FIT), Apple Inc. (NASDAQ: AAPL)
FIT: 16.27 (+0.33), PHG: 29.16 (+0.36), MDT: 87.14 (+0.78), AAPL: 113.55 (-0.02)
Biotricity Adds Two Members to Its Board of Advisors
GlobeNewswire - Mon Jun 06, 8:00AM CDT
Biotricity, Inc. (OTCQB:BTCY), a healthcare technology company dedicated to delivering innovative, medically relevant biometric remote monitoring solutions, has appointed Thomas Nelson and J. Bernard Rice to its newly formed Board of Advisors (BOA).
Biotricity to Present at LD Micro Invitational Investor Conference on June 7, 2016
ACCESSWIRE - Tue May 24, 8:01AM CDT
REDWOOD CITY, CA / ACCESSWIRE / May 24, 2016 / Biotricity, Inc. (OTCQB: BTCY), a healthcare technology company dedicated to delivering innovative, medically relevant biometric remote monitoring solutions, has been invited to present at the sixth annual LD Micro Invitational, being held June 7-9, 2016 at the Luxe Sunset Bel Air.
Biotricity Establishes Board of Advisors
GlobeNewswire - Tue May 10, 7:00AM CDT
Biotricity, Inc. (OTCQB:BTCY), a healthcare technology company dedicated to delivering innovative, medically relevant biometric remote monitoring solutions, has established its board of advisors comprised of policy leader and former AARP executive John Rother and healthcare informatics professional Dr. Danny Sands. This team of experts will provide non-binding strategic advice to Biotricity as it continues to develop its next generation wearable devices.
Biotricity Appoints Norman Betts to Board of Directors
GlobeNewswire - Wed Apr 27, 8:00AM CDT
Biotricity, Inc. (OTCQB:BTCY), a healthcare technology company dedicated to delivering innovative, medically relevant biometric remote monitoring solutions, has appointed financial professional Norman Betts to the company's board of directors. An accomplished accountant and professor, Betts also currently serves as a board member for the Bank of Canada, the country's central bank and the Canadian equivalent to the Federal Reserve. He is the second board member, and first independent, to join Biotricity with others expected to be added during the second quarter.
Over 70% of Americans Would Buy A Health Tracking Device if Clinically Accurate
ACCESSWIRE - Wed Apr 20, 7:00AM CDT
REDONDO BEACH, CA / ACCESSWIRE / April 20, 2016 / More than eight in ten consumers believe that tracking their own health data with a clinically accurate monitoring device will help improve their overall health, while over 70% of adults would use a personal monitoring device if it were clinically accurate, according to a survey commissioned by Biotricity Inc. (OTCQB: BTCY) and the Society for Participatory Medicine.
FIT: 16.27 (+0.33), CSII: 24.00 (+0.15), MDT: 87.14 (+0.78), BEAT: 18.65 (+0.43), CRY: 18.28 (+0.42), AAPL: 113.55 (-0.02)
Biometric Monitoring Solutions Provider, Biotricity, Begins Trading on the OTC QB Market as "BTCY"
GlobeNewswire - Wed Feb 03, 11:55AM CST
iMedical Innovation Inc., dba Biotricity, a healthcare technology company dedicated to delivering innovative, medically relevant biometric monitoring solutions, has completed a "reverse merger" transaction with Metasolutions Inc. (OTCQB:BTCY), a U.S.-based publicly-traded provider of, until the closing, energy intelligence management solutions, at which time all of its assets and liabilities were assigned to and assumed by a third party.
New Research From Biotricity and the Society for Participatory Medicine Finds Consumers Ready to Take Active Role in Managing Health & Illness
GlobeNewswire - Tue Feb 02, 9:00AM CST
Americans are fully prepared to take a more active role in managing their over-all health and are more than willing to wear personal monitoring devices to help themselves and medical professionals improve their care. According to a national survey of 1,000 respondents commissioned by The Society for Participatory Medicine and healthcare technology company Biotricity Inc., and more than 8 out of 10 consumers (84 percent) believe that tracking their own health data with a clinically accurate monitoring device will help improve their over-all health.
